Oversight of in-office dispensing and samples in dermatology

被引:3
作者
Heron, Courtney E. [1 ]
Purvis, Caitlin G. [1 ]
Balogh, Esther A. [1 ]
Purvis, Robert S. [2 ]
Feldman, Steven R. [1 ,3 ,4 ,5 ]
机构
[1] Wake Forest Sch Med, Ctr Dermatol Res, Dept Dermatol, Winston Salem, NC 27587 USA
[2] Grand Strand Dermatol, Myrtle Beach, SC USA
[3] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA
[4] Wake Forest Sch Med, Dept Social Sci & Hlth Policy, Winston Salem, NC USA
[5] Univ Southern Denmark, Dept Dermatol, Odense, Denmark
关键词
PRESCRIPTION DRUG SAMPLES; NATIONAL-SURVEY; UNITED-STATES; RECIPIENTS; ATTITUDES; OUTCOMES; PATIENT; CLOSET;
D O I
10.1016/j.clindermatol.2023.06.012
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The provision of samples and in-office dispensing of products and medications to patients are important, yet often controversial, practices in dermatology. Opinions on the practices of sampling and in-office dispensing vary greatly among dermatologists. Ultimately, there are several advantages and disadvantages associated with each practice, and common topics of discussion include ethics, costs, safety, and adherence. Many of the concerns associated with the practices of sampling and dispensing in dermatology may be mitigated by careful consideration and action by prescribers. Providers should be aware of their current practices surrounding these issues and, if used, methods by which these practices can be improved to optimize patient care. With careful consideration, it may be possible to practice sampling and dispensing of products and medications safely, ethically, and to the patients' advantage as an integral part of the dermatology practice.(c) 2023 Published by Elsevier Inc.
引用
收藏
页码:271 / 278
页数:8
相关论文
共 41 条
[1]   Do drug samples influence resident prescribing behavior? A randomized trial [J].
Adair, RF ;
Holmgren, LR .
AMERICAN JOURNAL OF MEDICINE, 2005, 118 (08) :881-884
[2]   Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs [J].
Alexander, G. Caleb ;
Zhang, James ;
Basu, Anirban .
MEDICAL CARE, 2008, 46 (04) :394-402
[3]   Drug samples in dermatology: Special considerations and recommendations for the future [J].
Alikhan, Ali ;
Sockolov, Mary ;
Brodell, Robert T. ;
Feldman, Steven R. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (06) :1053-1061
[4]  
Boltri JM, 2002, FAM MED, V34, P729
[5]   Regulations, liability, safety, and economics related to compounding [J].
Campbell, Elliott H. ;
Elston, Dirk M. ;
Straughan, Chad L. ;
Antonovich, Diana D. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) :184-188
[6]   A national survey of physician-industry relationships [J].
Campbell, Eric G. ;
Gruen, Russell L. ;
Mountford, James ;
Miller, Lawrence G. ;
Cleary, Paul D. ;
Blumenthal, David .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (17) :1742-1750
[7]   No More Free Drug Samples? [J].
Chimonas, Susan ;
Kassirer, Jerome P. .
PLOS MEDICINE, 2009, 6 (05)
[8]   Compounded Topical Analgesics for Chronic Pain [J].
Cline, Abigail E. ;
Turrentine, Jake E. .
DERMATITIS, 2016, 27 (05) :263-271
[9]   Free drug samples in the United States: Characteristics of pediatric recipients and safety concerns [J].
Cutrona, Sarah L. ;
Woolhandler, Steffie ;
Lasser, Karen E. ;
Bor, David H. ;
Himmelstein, David U. ;
Shrank, William H. ;
LeLeiko, Neal S. .
PEDIATRICS, 2008, 122 (04) :736-742
[10]   Characteristics of recipients of free prescription drug samples: A nationally representative analysis [J].
Cutrona, Sarah L. ;
Woolhandler, Steffie ;
Lasser, Karen E. ;
Bor, David H. ;
McCormick, Danny ;
Himmelstein, David U. .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2008, 98 (02) :284-289